NFL-101
N/A
Report date: 2023/01/01 08:29:38
NME
Base Information
Drug NameNFL-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNFL Biosciences SAS
China Registration ClassN/A
Develop Information
Active CompaniesNFL Biosciences SAS
Inactive CompaniesInstitut Regional Du Cancer De Montpellier
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A